Putting the Brakes on Tumorigenesis with Natural Products of Plant Origin: Insights into the Molecular Mechanisms of Actions and Immune Targets for Bladder Cancer Treatment
Bladder cancer is the 10th most commonly diagnosed cancer worldwide. Although the incidence in men is 4 times higher than that in women, the diagnoses are worse for women. Over the past 30 years, the treatment for bladder cancer has not achieved a significant positive effect, and the outlook for mor...
Main Authors: | Qiushuang Wu, Janet P. C. Wong, Hang Fai Kwok |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/5/1213 |
Similar Items
-
Decreased expression of SRY-box containing gene 30 is related to malignant phenotypes of human bladder cancer and correlates with poor prognosis
by: Yang Liu, et al.
Published: (2018-06-01) -
Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer
by: Amira Abugomaa, et al.
Published: (2020-01-01) -
Aloperine Exerts Antitumor Effects on Bladder Cancer in vitro
by: Zhang L, et al.
Published: (2020-10-01) -
Aberrantly expressed microRNAs in the context of bladder tumorigenesis
by: Jong-Young Lee, et al.
Published: (2016-06-01) -
Urinary bladder cancer: biomarkers and target therapy, new era for more attention
by: Amrallah A. Mohammed, et al.
Published: (2016-12-01)